HIGHLIGHTS
- who: Julien Ancel and collaborators from the , Reims, France Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liège, Liège, Belgium have published the article: Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC, in the Journal: Cancers 2019, x of /2019/
- what: The authors aimed to conjointly assess NSCLC the expression of PD-L1 and epithelial-mesenchymal transition frequently involved in tumor aggressiveness. With this in mind, the authors aimed to examine the potential correlation between vimentin and PD-L1 expression in NSCLC and their respective . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.